Exonate appoints Olav Hellebø as Chief Executive Officer
Appointment of experienced executive forms part of the Company’s strategy [...]
Welbeck Health Partners Adopts OMED Health’s Home-Based SIBO Testing Pathway Across Its Network
Patients complete SIBO breath testing at home, with diagnosis provided [...]
Tecan accelerates Data-Driven Lab journey with Agentic AI developments powered by NVIDIA
Männedorf, Switzerland, June 24, 2026: Tecan (SIX Swiss Exchange: TECN), [...]
FairJourney Bio and AbTherx Partner to Offer Fully Integrated Antibody Discovery
FairJourney Bio brings AbTherx’s Atlas transgenic mouse technologies in-house, enabling [...]
TRIMTECH Therapeutics brings total seed round to $47M with additional investment of $14M to further develop TRIMTAC and TRIMGLUE targeted protein degradation portfolio
Johnson & Johnson’s corporate venture capital organization, Johnson & Johnson [...]
Pheno Therapeutics granted FDA IND clearance for lead multiple sclerosis therapeutic candidate PTD802
US FDA clearance enables first-in-human study of PTD802, a selective [...]
Broken String Biosciences appoints Bruce Eaton PhD as Chairman of the Board
Strengthens Board with experienced industry executive, specializing in strategic planning, [...]
Laverock Therapeutics reports key oncology research milestones
London, UK, 10 June 2026: Laverock Therapeutics (‘Laverock’), a biotechnology [...]
PhoreMost announces lead oncology programme and appoints Chief Medical Officer to support clinical entry
Next-generation small molecule microtubule targeting agent, PMC-001, progressing towards Phase [...]
Bio-Rad Receives MicroVal Validation for EZ-CheckTM Listeria spp. and EZ-Check Listeria monocytogenes Testing Kits
Methods Certified by MicroVal for Detection of Listeria spp. and [...]